Tag

Eris Lifesciences Limited

2 articles

Eris Lifesciences Q4 FY26 Earnings Call Recording Available

Eris Lifesciences made its Q4 and FY26 earnings conference call recording available on its website in regulatory compliance. The call was held on May 20, 2026, to discuss audited standalone and consol

Eris Lifesciences Q4 FY26 Investor Presentation

Eris Lifesciences reported FY26 consolidated revenue growth of 8.1% to Rs. 3,129 crore and EBITDA growth of 10.1% to Rs. 1,120 crore. The Domestic Branded Formulations (DBF) segment grew 11% with a 37